Skip to main content
SpringerLink
Log in

Riluzole treatment in advanced ALS

  • Editorial
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bensimon G, Lacomblez L, Delumeau JC, Bejuit R, Truffinet P,Meininger V (2002) A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. J Neurol, this issue

  2. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V for the Amyotrophic Lateral Sclerosis Study Group II (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347:1425–1431

    Article  CAS  PubMed  Google Scholar 

  3. Louvel E, Hugon J, Doble A (1997) Therapeutic advances in amyotrophic lateral sclerosis. Trends Pharmacol Sci 18:196–203

    Article  CAS  PubMed  Google Scholar 

  4. National Institute for Clinical Excellence (2001) Guidance on the use of Riluzole (Rilutek) for the treatment of Motor Neurone Disease. National Institute for Clinical Excellence, London 2001

    Google Scholar 

  5. Quality Standards Subcommittee of the American Academy of Neurology (1997) Practice advisory on the treatment of Amyotrophic Lateral Sclerosis with riluzole. Neurology 149:657–659

    Article  Google Scholar 

  6. Centers LC (2002) Beyond denial and despair: ALS and our heroic potential for hope. J Palliat Care, in press

  7. Wasner M, Klier H, Borasio GD (2001) The use of alternative medicine by patients with amyotrophic lateral sclerosis. J Neurol Sci 191:151–154

    Article  CAS  PubMed  Google Scholar 

  8. Borasio GD, Sloan R, Pongratz DE (1998) Breaking the news in amyotrophic lateral sclerosis. J Neurol Sci 160 (Suppl. 1):S127–S133

    Article  PubMed  Google Scholar 

  9. Miller RG, Mitchell JD, Moore DH (2001) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) (Cochrane Review). In: The Cochrane Library, Issue 4, 2001. Oxford: Update Software

    Google Scholar 

  10. Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, Borasio GD, Bradley WG, Bromberg MB, Brooks BR, Kasarskis EJ, Munsat TL, Oppenheimer EA and the ALS Practice Parameters Task Force (1999) Practice Parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 52:1311–1323

    Article  CAS  PubMed  Google Scholar 

  11. Borasio GD, Voltz R, Miller RG (2001) Palliative Care in Amyotrophic Lateral Sclerosis. In: Carver A, Foley K (eds) Palliative Care. Neurol Clin of North Am 19:829–847

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Interdisciplinary Palliative Care Unit, Munich University Hospital - Grosshadern, Marchioninistr. 15, 81377, München, Germany

    Gian Domenico Borasio

Authors
  1. Gian Domenico Borasio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gian Domenico Borasio.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Borasio, G.D. Riluzole treatment in advanced ALS. J Neurol 249, 505–506 (2002). https://doi.org/10.1007/s004150200056

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004150200056

Search

Navigation